Tanvi Mehta
Overview
Explore the profile of Tanvi Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bramante C, Beckman K, Mehta T, Karger A, Odde D, Tignanelli C, et al.
Clin Infect Dis
. 2024 May;
79(2):354-363.
PMID: 38690892
Background: Metformin has antiviral activity against RNA viruses including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The mechanism appears to be suppression of protein translation via targeting the host mechanistic...
2.
Kamnev A, Mehta T, Wielscher M, Chaves B, Lacouture C, Mautner A, et al.
Cell Rep
. 2024 Feb;
43(3):113853.
PMID: 38421875
Actin cytoskeleton remodeling sustains the ability of cytotoxic T cells to search for target cells and eliminate them. We here investigated the relationship between energetic status, actin remodeling, and functional...
3.
Bramante C, Beckman K, Mehta T, Karger A, Odde D, Tignanelli C, et al.
medRxiv
. 2023 Jun;
PMID: 37333243
Current antiviral treatment options for SARS-CoV-2 infections are not available globally, cannot be used with many medications, and are limited to virus-specific targets. Biophysical modeling of SARS-CoV-2 replication predicted that...
4.
Bramante C, Buse J, Liebovitz D, Nicklas J, Puskarich M, Cohen K, et al.
Lancet Infect Dis
. 2023 Jun;
23(10):1119-1129.
PMID: 37302406
Background: Post-COVID-19 condition (also known as long COVID) is an emerging chronic illness potentially affecting millions of people. We aimed to evaluate whether outpatient COVID-19 treatment with metformin, ivermectin, or...
5.
Implementing real-time prescription benefit tools: Early experiences from 5 academic medical centers
Luo J, Wong R, Mehta T, Schwartz J, Epstein J, Smith E, et al.
Healthc (Amst)
. 2023 Mar;
11(2):100689.
PMID: 36989915
Background: Medication price transparency tools are increasingly available, but data on their use, and their potential effects on prescribing behavior, patient out of pocket (OOP) costs, and clinician workflow integration,...
6.
Mehta T, Malinovsky Y, Abnet C, Albert P
BMC Med Res Methodol
. 2022 Dec;
22(1):324.
PMID: 36526967
Background: The role of immunological responses to exposed bacteria on disease incidence is increasingly under investigation. With many bacterial species, and many potential antibody reactions to a particular species, the...
7.
Wong R, Mehta T, Very B, Luo J, Feterik K, Crotty B, et al.
J Gen Intern Med
. 2022 Nov;
38(4):1038-1045.
PMID: 36441366
The problem of unaffordable prescription medications in the United States is complex and can result in poor patient adherence to therapy, worse clinical outcomes, and high costs to the healthcare...
8.
Childerhose J, Alsamawi A, Mehta T, Smith J, Woolford S, Tarini B
Surg Obes Relat Dis
. 2017 Sep;
13(10):1768-1779.
PMID: 28958402
Bariatric surgery has been performed on adolescents since the 1970s, but little is known about the guidance offered to providers in recommendation documents published in the United States. A systematic...
9.
Fang L, Du W, Yang W, Rutnam Z, Peng C, Li H, et al.
Cell Cycle
. 2012 Nov;
11(23):4352-65.
PMID: 23111389
Here we report that miR-93, a miRNA in the miR-106B~25 cluster, a paralog of the miR-17-92 cluster, was significantly upregulated in human breast carcinoma tissues. We stably expressed miR-93 in...